Peptide or compound Primary category What researchers study Status context Semaglutide GLP-1 / metabolic Appetite, glucose, and cardiometabolic signaling FDA-approved products exist for specific indications Tirzepatide GIP/GLP-1 / metabolic Appetite, glucose, and metabolic signaling FDA-approved products exist for specific indications Retatrutide Triple agonist / metabolic GLP-1, GIP, and glucagon receptor signaling Investigational BPC-157 Tissue-repair research Gastrointestinal, tendon, and angiogenesis pathways Research-only
Why Muscle Loss Can Happen on GLP-1s Several factors can contribute to lean mass loss during GLP-1induced weight loss: reduced total calorie intake, inadequate protein intake, and lack of resistance training
As the popularity of these drugs continues to increase, the healthcare industry is looking at ways of reducing costs
Is compounded semaglutide dangerous
PMID 29364588
The reason they work is specific